Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Open-market sale President and CEO sold 50,000 shares at an average $7.71 ($385,250)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale President and CEO sold 50,000 shares at an average $8.04 ($402,000)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale President and CEO sold 50,000 shares at an average $7.38 ($368,750)
  12. 4 Open-market buy Vice President and CFO bought 3,268 shares at $6.30 ($20,583)
  13. 4 Open-market buy Chief Operating & Med. Officer bought 3,267 shares at $6.30 ($20,577)
  14. 4 Open-market sale President and CEO sold 50,000 shares at an average $8.59 ($429,250)
  15. 4/A Gift President and CEO gave 16,000 shares (gift)
  16. 4 Gift President and CEO gave 17,400 shares (gift)
  17. 4 Open-market sale President and CEO sold 50,000 shares at $8.16 ($408,000)
  18. 4 Option exercise Chief Operating & Med. Officer acquired 50,000 shares (option exercise)
  19. 4 Open-market buy 10% owner bought 174,700 shares at an average $9.11 ($1,592,016)
  20. 4 Open-market sale President and CEO sold 25,000 shares at $8.93 ($223,250)

Page 20 of 30 · 591 filings